lipoxin a4 has been researched along with E coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arita, M; Asano, K; Betsuyaku, T; Fukunaga, K; Miyasho, T; Miyata, J; Obata, T; Seki, H; Takeda, J; Ueda, T | 1 |
| Osuchowski, MF | 1 |
2 other study(ies) available for lipoxin a4 and E coli Infections
| Article | Year |
|---|---|
Combination therapy of 15-epi-lipoxin A4 with antibiotics protects mice from Escherichia coli-induced sepsis*.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftazidime; Drug Therapy, Combination; Escherichia coli Infections; Inflammation Mediators; Lipoxins; Macrophages; Male; Mice; Mice, Inbred C57BL; Peritonitis; Sepsis | 2014 |
Tender mediation in a ruthless environment: can lipoxins provide lifesaving modifications to fatally deregulated immunoinflammatory responses in sepsis?*.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Ceftazidime; Escherichia coli Infections; Lipoxins; Male; Sepsis | 2014 |